812. Case Control trial to evaluate the Cytokine response to the use of Capsule Thalidomide in Erythema nodosum leprosum in leprosy patients
Session: Poster Abstract Session: Tuberculosis and Other Mycobacterial Infections
Thursday, October 4, 2018
Room: S Poster Hall
Background: Leprosy is a chronic granulomatous disease caused by Mycobacterium leprae. Type II lepra reaction or Erythema Nodosum Leposum is a Type III hypersentivity immune response during the chronic course of the illness. This immune response presents as systemic symptoms and neutrophilic leukocytosis, similar to sepsis.Capsule Thalidomide is considered the drug of choice, when it comes to the treatment of this acute immunological emergency. A rational study into the immunological markers involved in the pathogenesis of erythema nododsum leprosum and its successful suppression by Thalidomide should be helpful in early diagnosis and prompt successful therapy. Based on the previous studies our aim was to find a correlation with Interferon-γ, Tumour necrosis factor-α and Cd-64 expression on activated circulating neutrophils during Type II lepra reaction and successful response to capsule Thalidomide.

Methods:

This case controlled study included one group of patients diagnosed to have leprosy and the other group was healthy controlled individuals with matched age, sex and area of residence. All the patients with type II lepra reaction responded to Capsule Thalidomide clinically and all the skin lesions resolved in 7-14 days. Blood samples and skin biopsy was subjected to histopathology, immunoflourescence assay, immunohistochemical staining, quantitative RT-PCR (Reverse Transcriptase-Polymerase Chain reaction) and flow cytometry.

Results: Interferon-γ and TNF-α are sensitive markers in diagnosing erythema nodosum leprosum and Cd-64 expression on activated circulating neutrophils is both a specific and sensitive marker in Type II Lepra reaction. Cd-64 expression also had a positive correlation with Thalidomide treatment and clinical response. High polymorphonuclear Cd-64 expression was correlated with severity of ENL.

Conclusion: Cd-64 expression on circulating neutrophils is a potential early biophysical marker for diagnosing erythema nodosum leprosum and can be used as a tool to assess thalidomide response. It is however not a good index to diagnose leprosy infection as it was specific for Type II lepra reaction. Interferon-γ and TNF-α are sensitive markers to screen for lepra reactions and this study showed no significant correlation with Thalidomide therapy.

Ajay Chopra, MD Dermatology, Dermatology, base hospital delhi cantt, new delhi, India, Debdeep Mitra, MD Dermatology, Dermatology, Army Hospital New Delhi, New Delhi, India and Barnali Mitra, MD Pediatrics, Department of Pediatrics, Base Hospital Delhi Cantt, New Delhi, India

Disclosures:

A. Chopra, None

D. Mitra, None

B. Mitra, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.